SIMCERE PHARMAC. GRP LTD Free Cash Flow Generation Index
SIMCERE PHARMAC. GRP LTD free cash flow generation index. SIMCERE PHARMAC. GRP LTD (S2P) has a Free Cash Flow Generation Index of 0.57x as of December 2025. Free cash flow of €1.15 Billion represents 1% of operating cash flow (€2.01 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of SIMCERE PHARMAC. GRP LTD (2022–2025)
Free cash flow generation index of SIMCERE PHARMAC. GRP LTD from 2022 to 2025. Historical FCF Generation Index trend for SIMCERE PHARMAC. GRP LTD across 4 annual periods. See SIMCERE PHARMAC. GRP LTD financial flexibility index to measure the company's free cash flow as a share of total liabilities.
SIMCERE PHARMAC. GRP LTD Free Cash Flow Generation Index by Year (2022–2025)
SIMCERE PHARMAC. GRP LTD free cash flow generation index by year from 2022 to 2025. Year-by-year Free Cash Flow Generation Index for SIMCERE PHARMAC. GRP LTD. For the full cash flow conversion analysis, see SIMCERE PHARMAC. GRP LTD operating cash flow efficiency.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.57x | €1.15 Billion | €2.01 Billion | €862.20 Million | ▲ +26.6% |
| 2024 | 0.45x | €628.54 Million | €1.39 Billion | €762.57 Million | ▲ +108.2% |
| 2023 | -5.49x | €-828.81 Million | €151.05 Million | €979.86 Million | ▼ -1199.0% |
| 2022 | 0.50x | €676.09 Million | €1.35 Billion | €678.00 Million | — |